A Study to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or Overweight (VESPER-SUI)
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07932925. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF BEROBENATIDE IN ADULT FEMALE PARTICIPANTS WITH STRESS URINARY INCONTINENCE AND WITH OBESITY OR OVERWEIGHT (VESPER-SUI)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to learn about the safety and effectiveness of berobenatide in adult women who have both stress urinary incontinence (SUI) and obesity or overweight. Participants will be in the study for about 63 weeks
Study identification
- NCT ID
- NCT07932925
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 900 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 17, 2026 (Estimated)
- Primary completion
- Oct 13, 2028 (Estimated)
- Completion
- Dec 1, 2028 (Estimated)
- Last update posted
- Nov 19, 2026
2026 – 2028
United States locations
- U.S. sites
- 10
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Madison Imaging Center | Citrus Heights | California | 95610 | Recruiting |
| Northern California Research | Sacramento | California | 95821 | Recruiting |
| Hawthorne Health - Boynton Beach, FL | Boynton Beach | Florida | 33436 | Recruiting |
| Well Pharma Medical Research | Miami | Florida | 33173 | Not yet recruiting |
| New Age Medical Research Corporation | Miami | Florida | 33186 | Recruiting |
| IMA Clinical Research | Warren Township | New Jersey | 07059 | Not yet recruiting |
| University Radiology Group | Warren Township | New Jersey | 07059 | Not yet recruiting |
| Hawthorne Health - Horsham, PA | Horsham | Pennsylvania | 19044 | Recruiting |
| Clinical Trial Network | Houston | Texas | 77074 | Recruiting |
| Northwest Clinical Research Center | Bellevue | Washington | 98007 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07932925, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 19, 2026 · Synced Nov 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.